Your browser doesn't support javascript.
loading
Improving Case-Based Meningitis Surveillance in 5 Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
Mbaeyi, Sarah A; Lingani, Clement; Diallo, Alpha Oumar; Bicaba, Brice; Ouédraogo-Traoré, Rasmata; Acyl, Mahamat; Gamougame, Kadidja; Coulibaly, Oumou; Coulibaly, Souleymane; Zaneidou, Maman; Sidikou, Fati; Nikiema, Christelle; Sadji, Adodo Yao; Aké, Flavien; Tarbangdo, Félix; Sakande, Souleymane; Tall, Haoua; Njanpop-Lafourcade, Berthe-Marie; Moïsi, Jennifer; N'diaye, Aboubacar; Bwaka, Ado; Bita, Andre; Fernandez, Katya; Poy, Alain; Soeters, Heidi M; Vuong, Jeni; Novak, Ryan; Ronveaux, Olivier.
Afiliação
  • Mbaeyi SA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Lingani C; World Health Organization, AFRO Intercountry Support Team for West Africa, Ouagadougou, Burkina Faso.
  • Diallo AO; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bicaba B; Ministère de la Santé du Burkina Faso, Ouagadougou.
  • Ouédraogo-Traoré R; Ministère de la Santé du Burkina Faso, Ouagadougou.
  • Acyl M; Ministère de la Santé Publique du Tchad, N'Djamena.
  • Gamougame K; Ministère de la Santé Publique du Tchad, N'Djamena.
  • Coulibaly O; Ministère de la Santé et de l'Hygiène Publique du Mali, Bamako, Mali.
  • Coulibaly S; Ministère de la Santé et de l'Hygiène Publique du Mali, Bamako, Mali.
  • Zaneidou M; Ministère de la Santé Publique du Niger, Niamey.
  • Sidikou F; Ministère de la Santé Publique du Niger, Niamey.
  • Nikiema C; Ministère de la Santé et de la Protection Sociale du Togo, Lomé.
  • Sadji AY; Ministère de la Santé et de la Protection Sociale du Togo, Lomé.
  • Aké F; Davycas International, Ouagadougou, Burkina Faso.
  • Tarbangdo F; Davycas International, Ouagadougou, Burkina Faso.
  • Sakande S; Agence de Médecine Préventive, Ouagadougou, Burkina Faso.
  • Tall H; Agence de Médecine Préventive, Ouagadougou, Burkina Faso.
  • Njanpop-Lafourcade BM; Agence de Médecine Préventive, Paris, France.
  • Moïsi J; Agence de Médecine Préventive, Paris, France.
  • N'diaye A; World Health Organization, Intercountry Support Team for Central Africa, Libreville, Gabon.
  • Bwaka A; World Health Organization, AFRO Intercountry Support Team for West Africa, Ouagadougou, Burkina Faso.
  • Bita A; World Health Organization, AFRO Intercountry Support Team for West Africa, Ouagadougou, Burkina Faso.
  • Fernandez K; World Health Organization, Geneva, Switzerland.
  • Poy A; World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.
  • Soeters HM; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Vuong J; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Novak R; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Ronveaux O; World Health Organization, Geneva, Switzerland.
J Infect Dis ; 220(220 Suppl 4): S155-S164, 2019 10 31.
Article em En | MEDLINE | ID: mdl-31671451
ABSTRACT

BACKGROUND:

The MenAfriNet consortium was established in 2014 to support implementation of case-based meningitis surveillance in 5 countries in the meningitis belt of sub-Saharan Africa Burkina Faso, Chad, Mali, Niger, and Togo. Assessing surveillance performance is critical for interpretation of the collected data and implementation of future surveillance-strengthening initiatives.

METHODS:

Detailed epidemiologic and laboratory data were collected on suspected meningitis cases through case-based meningitis surveillance in participating districts in 5 countries. Performance of case-based surveillance was evaluated through sensitivity of case ascertainment in case-based versus aggregate meningitis surveillance and an analysis of surveillance indicators.

RESULTS:

From 2015 to 2017, 18 262 suspected meningitis cases were identified through case-based surveillance and 16 262 were identified through aggregate surveillance, for a case ascertainment sensitivity of 112.3%. Among suspected cases, 16 885 (92.5%) had a cerebrospinal fluid (CSF) specimen collected, 13 625 (80.7%) of which were received at a national reference laboratory. Among these, 13 439 (98.6%) underwent confirmatory testing, and, of those tested, 4371 (32.5%) were confirmed for a bacterial pathogen.

CONCLUSIONS:

Overall strong performance for case ascertainment, CSF collection, and laboratory confirmation provide evidence for the quality of MenAfriNet case-based surveillance in evaluating epidemiologic trends and informing future vaccination strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vigilância da População / Meningite Meningocócica / Neisseria meningitidis Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vigilância da População / Meningite Meningocócica / Neisseria meningitidis Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article